Ezh2, A NOVEL TARGET IN TREATMENT OF MEDULLOBLASTOMA

被引：0
|
作者：
Ricke, Brandon [1 ]
Shah, Kushal [1 ]
Salacz, Michael [1 ]
Camarata, Paul [1 ]
Lovick, Darren [2 ]
Peng, Warner [1 ]
Dolatkhah, Roya [1 ]
Sanaat, Zohreh [1 ]
Kimura, Kyle [1 ]
Bi, Danse [1 ]
Taylor, Sarah [1 ]
Esfandyari, Tuba [1 ]
Farassati, Faris [1 ]
机构：
[1] Univ Kansas, Sch Med, Kansas City, KS USA
[2] Univ Missouri, Sch Med, St Lukes Hosp, Kansas City, KS USA
来源：
NEURO-ONCOLOGY | 2015年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TR-01
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [21] EZH2 as a Novel Target for Aggressive Clear Cell Renal Cell Carcinoma
    Friedman, Paul
    Christie, Alana
    Xie, Xian-Jin
    Rakheja, Dinesh
    Brugarolas, James
    Kapur, Payal
    LABORATORY INVESTIGATION, 2016, 96 : 230A - 230A
  • [22] Novel PROTAC-based EZH2 Degraders Effectively Target Lymphoid Malignancies by Depleting Enzyme-Independent Functions of EZH2
    Mustafa, Nurulhuda
    Alnaseri, Zubaida Talal
    Jian, Darrel Tan Egk
    Truong, David Quach Thanh
    Lim, Wan Hsin
    Chng, Wee Joo
    CANCER RESEARCH, 2024, 84 (08)
  • [23] The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer
    Li, Zhongwu
    Wang, Yanling
    Qiu, Jing
    Li, Qiang
    Yuan, Chunping
    Zhang, Wei
    Wang, Dongmiao
    Ye, Jinhai
    Jiang, Hongbin
    Yang, Jianrong
    Cheng, Jie
    ONCOTARGET, 2013, 4 (12) : 2532 - 2549
  • [24] EZH2 as a Novel Target for Aggressive Clear Cell Renal Cell Carcinoma
    Friedman, Paul
    Christie, Alana
    Xie, Xian-Jin
    Rakheja, Dinesh
    Brugarolas, James
    Kapur, Payal
    MODERN PATHOLOGY, 2016, 29 : 230A - 230A
  • [25] The histone methyltransferase EZH2 is a novel target of anticancer therapy in endometrial cancer
    Oki, Shinya
    Sone, Kenbun
    Oda, Katsutoshi
    Nishijima, Akira
    Takeuchi, Makoto
    Agapiti, Chuwa
    Asada, Kayo
    Makii, Chinami
    Kawana, Kei
    Osuga, Yutaka
    Fuji, Tomoyuki
    CANCER RESEARCH, 2016, 76
  • [26] EZH2 inhibitor and Vismodegib synergistically inhibit the growth and metastasis of medulloblastoma
    Chao Xu
    Bohong Wang
    Tao Xu
    Yao Lv
    Xiani Pan
    Xiangmao Zhao
    Feng Tan
    Hansong Sheng
    Lisheng Yu
    Medical Oncology, 42 (6)
  • [27] The role of EZH2 as a potential therapeutic target in retinoblastoma
    Zhao, Yuqing
    Cheng, Ying
    Qu, Yi
    EXPERIMENTAL EYE RESEARCH, 2023, 227
  • [28] EZH2 serves as a promising therapeutic target for fibrosis
    Zhang, Qian
    Wu, Ya-Xi
    Yu, Xiao-Qian
    Zhang, Bao-Yin
    Ma, Li-Ying
    BIOORGANIC CHEMISTRY, 2023, 137
  • [29] EZH2 Expression in Retinoblastoma: a Potential Therapeutic Target
    Lin, Zhuangling
    Tang, Lijuan
    Chen, Shuxia
    Zhang, Wenxin
    Lin, Jianxian
    Gao, Huanhuan
    Zhang, Ping
    OPHTHALMIC RESEARCH, 2023, 66 (01) : 1014 - 1019
  • [30] EZH2 in Bladder Cancer, a Promising Therapeutic Target
    Martinez-Fernandez, Monica
    Rubio, Carolina
    Segovia, Cristina
    Lopez-Calderon, Fernando F.
    Duenas, Marta
    Paramio, Jesus M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (11): : 27107 - 27132
12345